MannKind to Present at the JMP Securities Life Sciences Conf

[kite]

www.globenewswire.com/news-release/2019/06/12/1867618/0/en/MannKind-to-Present-at-the-JMP-Securities-Life-Sciences-Conference.html


WESTLAKE VILLAGE, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the JMP Securities Life Sciences Conference at 9:00 AM (ET) on June 19, 2019. The conference is being held at The St. Regis in New York.



Michael Castagna, Chief Executive Officer, of MannKind Corporation, will provide an overview of the Company's business during the live presentation. Steven B. Binder, Chief Financial Officer, will participate in one-on-one meetings with investors who are registered to attend the conference.



The presentation will be webcast live. Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation.



About MannKind Corporation

MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company's first FDA-approved product and the only orally inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.



Company Contact:

Rose Alinaya

Investor Relations

818-661-5000

[e-mail]



Source: MannKind Corporation

[mnkdfann]

jmpls.ljfevents-rsvp.com/

JMP Securities invites you to attend its annual life sciences equity research conference, which brings institutional investors together with senior executives of leading publicly traded and privately held companies in the areas of biopharmaceuticals, biotechnology, and medical devices and technologies. Fireside chats and thematic panel discussions incorporating a range of senior executives, key opinion leaders, practitioners and patients will highlight the primary trends shaping the life sciences marketplace today.

[awesomo]

Looks like MNKD hasn’t attended this since 2015, also interesting that the CFO is going for one on one meetings.

[tiberious]

Ultra is Ultra interesting to me. 

MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company's first FDA-approved product and the only orally inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide

So are we officially Ultra now?  I hope so!

[goyocafe]

Jun 12, 2019 9:22:50 GMT -5 tiberious said:

Ultra is Ultra interesting to me. 

MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company's first FDA-approved product and the only orally inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide

So are we officially Ultra now?  I hope so!

Shhhhh! Don't tell anyone.

[sportsrancho]

ST...$MNKD Confirmed from MC just a bit ago the ultra rapid label is for Brazil only at this time and reps in US will not make these claims. Hope that helps clear up the confusion a bit. I know they have never stopped working to gain it here in the states though. 100% positive they will achieve this goal.

[kimi]

source please

Thanks

[sportsrancho]

Jun 12, 2019 13:04:25 GMT -5 kimi said:

source please

Thanks

Well most of the time I don’t give out my sources, but I’ll tell you it was laborer on StockTwits (his son is on Afrezza, he talks to Mike frequently.

[kite]

Biomm has already placed an order for Afrezza... and has been receiving a lot of media attention in Brazil

[kite]

Overall the presentation at the JMP Securities Life Sciences Conference is very positive.

Afrezza is going to be around in the long run. For now just continue to block out the negative noise and the current stock price lol

That's my take on it.

[rtmd]

Jun 19, 2019 8:07:03 GMT -5 kite said:

Biomm has already placed an order for Afrezza... and has been receiving a lot of media attention in Brazil

Has Mannkind announced anything to that effect?

[centralcoastinvestor]

Good presentation in my opinion.  Growing Afrezza is going to take grit and patience.  That’s just the way it is.  I am in this for the long haul so I am doing my best to ignore the immense amount of negative noise that has been flying around lately.  It still appears that Mike C has a good long term plan and is executing that plan.  

[kite]

Jun 19, 2019 8:34:26 GMT -5 centralcoastinvestor said:

Good presentation in my opinion.  Growing Afrezza is going to take grit and patience.  That’s just the way it is.  I am in this for the long haul so I am doing my best to ignore the immense amount of negative noise that has been flying around lately.  It still appears that Mike C has a good long term plan and is executing that plan.  

I agree 100%. We are moving in the positive direction and success does not develop overnight. I believe in MC

[cjm18]

Runway still to middle of next year.

Undisclosed compound is on the slides. Didn’t get the details on that. I can’t see how they expect to get to middle of next year without that 30m

One of the people asking about kaiser was impressed. Don’t know if he was already covering mannkind or not.

[ltta]

Jun 19, 2019 8:42:55 GMT -5 cjm18 said:

Runway still to middle of next year.

Undisclosed compound is on the slides. Didn’t get the details on that. I can’t see how they expect to get to middle of next year without that 30m

One of the people asking about kaiser was impressed. Don’t know if he was already covering mannkind or not.

I thought I heard in the beginning of the presentation...  MC say they were meeting with partners in SF while presenting at the ADA.  Kaiser SF??  I'll have to go back and listen again.